Benign Prostatic Hyperplasia Treatment Market Report 2021-26: Trends, Size, Leading Companies, Industry Growth and Opportunity

According to IMARC Group’s latest report, titled “Benign Prostatic Hyperplasia Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global benign prostatic hyperplasia treatment market reached a value of US$ 10.5 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 5.6% during 2021-2026.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally–our estimates about the latest market trends and forecast values after considering the impact of this pandemic. These observations will be integrated into the report.

Request for a free sample copy of this report: https://www.imarcgroup.com/benign-prostatic-hyperplasia-treatment-market/requestsample

Benign prostatic hyperplasia (BPH) refers to non-cancerous growth of the prostate gland that causes urethra blockage. This disorder generally results in the retention of urine, formation of bladder stones, incontinence due to overfilling, increased sensitivity of the bladder, and urinary tract infections. Some commonly used treatment methods for BPH include prescription drugs, mono drug and combination therapy, Phyto-therapies, and minimally-invasive (MI) and invasive surgeries. Resectoscopes, radiofrequency ablation devices, urology lasers, prostatic stents, and implants are some of the standard instruments used in BPH treatment surgeries.

Market Trends and Drivers:

The rising prevalence of urological disorders across the globe, coupled with the growing geriatric population, is currently driving the benign prostatic hyperplasia treatment market growth. Furthermore, the increasing consumer awareness towards the availability of efficient and minimally-invasive treatment procedures for BPH is also propelling the market. Moreover, various advancements in the medical sector have led to the development of transurethral resection of the prostate (TURP) as an efficient treatment technique. TURP is an endoscopic electrosurgical procedure that removes a portion of the prostate gland to reduce the obstruction caused by abnormal growth. In addition to this, the rising healthcare expenditures and improving healthcare infrastructures will continue to drive the market growth in the coming years.

Benign Prostatic Hyperplasia Treatment Market 2021-2026 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the benign prostatic hyperplasia treatment market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

• Abbott Laboratories
• GlaxoSmithKline Plc
• Boston Scientific Corporation
• Pfizer Inc.
• Asahi Kasei Corporation
• Sanofi S.A.
• Teva Pharmaceutical Industries Ltd.
• Allergan Plc (AbbVie Inc.)
• Astellas Pharma Inc.
• Boehringer Ingelheim GmbH (C.H. Boehringer Sohn AG & Ko. KG)

Key Market Segmentation:

The report has segmented the global benign prostatic hyperplasia treatment market on the basis of treatment and region.

Market Breakup by Treatment:

• Drug Class
  • Alpha-Blockers
  • 5-Alpha-reductase Inhibitors (5-ARIs)
  • Phosphodiesterase-5 Enzyme Inhibitors
  • Others
• Minimally Invasive Surgeries
  • Transurethral Resection of the Prostate (TURP)
  • Transurethral Incision of the Prostate (TUIP)
  • Transurethral Microwave Thermotherapy (TUMT)
  • Robotic Surgeries
  • Prostatic Urethral Lifts
  • Others
• Laser Therapy
• Others

Market Breakup by Region:

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/benign-prostatic-hyperplasia-treatment-market

Key Highlights of the Report:

• Market Performance (2015-2020)
• Market Outlook (2021-2026)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• The Impact of COVID-19 on the Global Market
• Value Chain Analysis
• Structure of the Global Market
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800